ASHER BIOTHERAPEUTICS
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90331121
- Registration number
- 7013050
- Mark type
- Stylized text
- Filed
- 19 Nov 2020
- Published for opposition
- 09 Nov 2021
- Registered
- 28 Mar 2023
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of viral, oncological, and immune system related diseases and disorders; medical preparations for the treatment of viral, oncological, and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Medical research; pharmaceutical research services; pharmaceutical research and development; scientific research for medical purposes in the fields of cancerous diseases, immunotherapy, autoimmune diseases and disorders, and infectious diseases; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of cancer, immunological diseases and disorders, and infectious diseases; research and development of immunotherapies for the treatment of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Asher Biotherapeutics, Inc., South San Francisco, CA, US
- Asher Biotherapeutics, Inc., South San Francisco, CA, US
- Asher Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 18 Sept 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Jan 2023 — SOU EXTENSION 2 GRANTED
- 04 Jan 2023 — SOU EXTENSION 2 FILED
- 04 Jan 2023 — USE AMENDMENT FILED
- 19 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jan 2023 — SOU TEAS EXTENSION RECEIVED